Brian E. Mcdowell

Array ( [id] => 6236658 [patent_doc_number] => 20100267752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => '3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/579231 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13614 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267752.pdf [firstpage_image] =>[orig_patent_app_number] => 12579231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167444 [patent_doc_number] => 20110195949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => '2-BENZOTHIOPHENYL- AND 2-NAPHTHYL-OXAZOLIDINONES AND THEIR AZAISOSTERE ANALOGUES AS ANTIBACTERIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/123707 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21758 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195949.pdf [firstpage_image] =>[orig_patent_app_number] => 13123707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801098 [patent_doc_number] => 08129368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => '5,6-dihydro-1H-pyridin-2-one compounds' [patent_app_type] => utility [patent_app_number] => 12/576739 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22847 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129368.pdf [firstpage_image] =>[orig_patent_app_number] => 12576739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064254 [patent_doc_number] => 20110201595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'OXAZOLIDINYL ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 13/123708 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18935 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201595.pdf [firstpage_image] =>[orig_patent_app_number] => 13123708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016741 [patent_doc_number] => 20110224201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/121784 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16227 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224201.pdf [firstpage_image] =>[orig_patent_app_number] => 13121784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258544 [patent_doc_number] => 20100029943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALLY PURE ESZOPICLONE AND OPTICALLY ENRICHED ESZOPICLONE' [patent_app_type] => utility [patent_app_number] => 12/565971 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5710 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029943.pdf [firstpage_image] =>[orig_patent_app_number] => 12565971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595853 [patent_doc_number] => 20100048576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/566362 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84833 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048576.pdf [firstpage_image] =>[orig_patent_app_number] => 12566362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257645 [patent_doc_number] => 20100029694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Heterocyclic compounds and their use as aldosterone synthase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/585584 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7270 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029694.pdf [firstpage_image] =>[orig_patent_app_number] => 12585584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016855 [patent_doc_number] => 20110224230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'BICYCLIC DIHYDROIMIDAZOLONE CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/119534 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20050 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224230.pdf [firstpage_image] =>[orig_patent_app_number] => 13119534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534818 [patent_doc_number] => 07888373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Heterocyclic sulfonamides as modulators of cardiac sarcomeres' [patent_app_type] => utility [patent_app_number] => 12/553311 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18547 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888373.pdf [firstpage_image] =>[orig_patent_app_number] => 12553311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613282 [patent_doc_number] => 07989463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Biccyclic compounds as GATA modulators' [patent_app_type] => utility [patent_app_number] => 12/553694 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28033 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989463.pdf [firstpage_image] =>[orig_patent_app_number] => 12553694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497801 [patent_doc_number] => 20100094000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PYRAZOLE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/552701 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90776 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20100094000.pdf [firstpage_image] =>[orig_patent_app_number] => 12552701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292441 [patent_doc_number] => 20100065123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Electrically conducting porphyrin and porphyrin-fullerene electropolymers' [patent_app_type] => utility [patent_app_number] => 12/552187 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11618 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20100065123.pdf [firstpage_image] =>[orig_patent_app_number] => 12552187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398463 [patent_doc_number] => 08268843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => '5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals' [patent_app_type] => utility [patent_app_number] => 12/550952 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20658 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12550952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959602 [patent_doc_number] => 20110183989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'SATURATED BICYCLIC HETEROCYCLIC DERIVATIVES AS SMO ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/060718 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30185 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183989.pdf [firstpage_image] =>[orig_patent_app_number] => 13060718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359946 [patent_doc_number] => 20100087459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'FORMS OF LAPATINIB COMPOUNDS AND PROCESSES FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/548103 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8954 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087459.pdf [firstpage_image] =>[orig_patent_app_number] => 12548103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618924 [patent_doc_number] => 20100099871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'ANTI-PSYCHOTIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS\nTHEREOF' [patent_app_type] => utility [patent_app_number] => 12/542556 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17287 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099871.pdf [firstpage_image] =>[orig_patent_app_number] => 12542556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329627 [patent_doc_number] => 20100197915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'LAPATINIB INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 12/536972 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9914 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197915.pdf [firstpage_image] =>[orig_patent_app_number] => 12536972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083874 [patent_doc_number] => 20110144084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => '6 SUBSTITUTED 2- HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/057558 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144084.pdf [firstpage_image] =>[orig_patent_app_number] => 13057558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8174203 [patent_doc_number] => 20120108817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'ACETYL PYRROLIDINYL INDOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/058626 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13202 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108817.pdf [firstpage_image] =>[orig_patent_app_number] => 13058626 [rel_patent_id] =>[rel_patent_doc_number] =>)